Article
Systemic lupus erythematosus: all roads lead to type I interferons.
Current opinion in immunology - 1 Dec 2006
Pascual Virginia, Farkas Lorant, Banchereau Jacques
Abstract excerpt
In recent years, the study of systemic lupus erythematosus (SLE) patients has revealed a central role for type I interferon (IFN) in disease pathogenesis. IFN induces the unabated activation of peripheral dendritic cells, which select and activate autoreactive T cells rather than deleting them, thus failing to induce peripheral tolerance. IFN also directly affects T cells and B cells. Furthermore, immune...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
